Word of the president
We are pleased to welcome you at the 10th Paris Hepatology Conference (PHC).
As usual, the meeting will provide state of the art information on the management of patients with liver disease by highly renowned international experts who will present the most recent results in the field and their clinical applications.
Thanks to the outstanding progress made in the treatment of hepatitis C with the new direct acting antiviral combinations, almost all these patients can now potentially be cured, including formerly «difficult to treat» patients (those with cirrhosis, co-infection with HIV and transplantation…). These combinations are well tolerated and highly effective with shorter treatment (high SVR rates after 12 weeks of treatment and a significant proportion of the population that responds after only 8 weeks).
APHP Hôpital Beaujon,
and CRI – Inserm.